Skip to main content
Premium Trial:

Request an Annual Quote

The Times Talks Tenure

As part of a Room for Debate discussion forum, the New York Times asks: "What if college tenure dies?" Cary Nelson at the University of Illinois, Urbana-Champaign, says that "the only way to preserve and rebuild our higher education system is to grant long-term adjunct faculty members the protections of tenure and appoint more tenure track faculty," while Ohio University's Richard Vedder says "tenured faculty members often use their power to stifle innovation and change," and that "tenure contributes to the inefficient and expensive system of shared governance." Adrianna Kezar at the University of Southern California writes in defense of tenure, while Harvard's Cathy Trower and Columbia's Mark Taylor each shoot the practice down (Taylor calls the practice "unsustainable and indefensible."). Hundreds of reader comments round out the discussion, which was posted, and updated, this week.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.